hcpcs_code stringlengths 5 5 | hcpcs_description stringlengths 10 256 | n_providers int64 1 498k | total_services int64 408k 102M | total_medicare_payment int64 11.8k 8.43B | avg_submitted_charge int64 0 9.01k |
|---|---|---|---|---|---|
J3032 | Injection, eptinezumab-jjmr, 1 mg | 108 | 947,084 | 13,302,963 | 46 |
83521 | Measurement of immunoglobulin light chains | 848 | 946,023 | 15,985,759 | 122 |
Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 470 | 937,303 | 169,309,392 | 741 |
17311 | Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks | 3,051 | 933,225 | 417,113,225 | 1,529 |
76705 | Limited ultrasound scan of abdomen | 19,014 | 932,866 | 24,477,344 | 182 |
J1885 | Injection, ketorolac tromethamine, per 15 mg | 7,319 | 930,781 | 454,486 | 14 |
86334 | Immunologic analysis technique on serum (immunofixation) | 1,793 | 929,702 | 16,701,156 | 125 |
J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 9,510 | 921,903 | 827,245 | 15 |
93793 | Anticoagulant management of patient taking warfarin | 3,717 | 915,170 | 6,847,853 | 42 |
82248 | Bilirubin level, direct | 1,111 | 911,778 | 4,451,822 | 24 |
73610 | X-ray of ankle, minimum of 3 views | 20,868 | 906,913 | 14,315,666 | 83 |
76536 | Ultrasound scan of head and neck soft tissue | 14,783 | 901,656 | 43,860,579 | 243 |
84436 | Thyroxine (thyroid chemical), total | 1,171 | 885,693 | 5,956,899 | 43 |
96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 3,990 | 883,718 | 19,294,172 | 121 |
98942 | Chiropractic manipulative treatment, 5 spinal regions | 2,539 | 883,182 | 32,032,161 | 74 |
88307 | Pathology examination of tissue using a microscope, moderately high complexity | 8,514 | 881,889 | 59,335,934 | 364 |
83880 | Natriuretic peptide (heart and blood vessel protein) level | 2,208 | 874,498 | 33,597,297 | 172 |
87640 | Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 1,107 | 872,817 | 29,980,573 | 58 |
J2323 | Injection, natalizumab, 1 mg | 31 | 870,734 | 15,576,525 | 46 |
64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | 8,175 | 867,623 | 177,263,435 | 1,882 |
93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | 11,719 | 845,958 | 8,595,371 | 78 |
77427 | Radiation treatment management, 5 treatment sessions | 4,602 | 843,253 | 126,035,212 | 753 |
J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 86 | 840,201 | 8,976,024 | 38 |
97016 | Application of blood vessel compression device | 4,548 | 838,466 | 5,540,612 | 45 |
96127 | Assessment of emotional or behavioral problems | 9,200 | 833,787 | 2,609,909 | 23 |
J0875 | Injection, dalbavancin, 5 mg | 97 | 833,120 | 9,999,614 | 37 |
97035 | Application of ultrasound, each 15 minutes | 4,432 | 831,465 | 6,763,051 | 37 |
95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | 6,466 | 822,155 | 55,877,686 | 295 |
73110 | X-ray of wrist, minimum of 3 views | 18,651 | 816,983 | 14,712,521 | 93 |
78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | 6,683 | 816,970 | 395,726,973 | 2,121 |
G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatm | 828 | 813,225 | 179,898,016 | 274 |
J0586 | Injection, abobotulinumtoxina, 5 units | 72 | 812,876 | 5,183,256 | 16 |
88112 | Cell examination of specimen, selective cellular enhancement technique | 4,818 | 812,667 | 23,802,074 | 185 |
17004 | Destruction of precancer skin growth, 15 or more growths | 10,014 | 807,938 | 93,928,956 | 366 |
96401 | Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 4,196 | 804,941 | 44,614,959 | 195 |
87653 | Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 974 | 804,203 | 27,635,710 | 58 |
95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 6,772 | 802,216 | 19,706,819 | 107 |
93297 | Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 2,697 | 801,728 | 27,446,123 | 155 |
52000 | Diagnostic exam of bladder and urethra using an endoscope | 8,677 | 800,242 | 120,811,085 | 804 |
87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 8,131 | 798,991 | 40,035,029 | 126 |
70498 | Ct scan of blood vessels of neck with contrast | 12,868 | 785,257 | 48,928,168 | 487 |
87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 12,806 | 783,946 | 31,519,685 | 150 |
G0249 | Provision of test materials and equipment for home inr monitoring of patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; includes: provision of materials for use in the | 62 | 779,062 | 49,103,187 | 340 |
93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 7,613 | 778,779 | 40,308,682 | 290 |
88304 | Pathology examination of tissue using a microscope, moderately low complexity | 8,727 | 773,344 | 12,566,236 | 111 |
94010 | Test to measure expiratory airflow and volume | 8,547 | 767,392 | 12,191,892 | 87 |
J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg | 122 | 765,969 | 2,648,722 | 11 |
70496 | Ct scan of blood vessels of head with contrast | 12,590 | 757,050 | 48,854,982 | 469 |
94060 | Test to measure expiratory airflow and volume changes before and after medication administration | 8,949 | 753,303 | 15,935,987 | 124 |
99283 | Emergency department visit with low level of medical decision making | 26,054 | 744,464 | 36,284,360 | 403 |
J2704 | Injection, propofol, 10 mg | 393 | 736,133 | 59,732 | 11 |
11055 | Removal of noncancer thickened skin growth, 1 growth | 6,779 | 734,657 | 35,962,559 | 113 |
R0070 | Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen | 286 | 723,699 | 127,887,522 | 381 |
J1434 | Injection, fosaprepitant (focinvez), 1 mg | 107 | 723,351 | 1,678,747 | 9 |
31231 | Diagnostic exam of nasal passages using an endoscope | 6,468 | 718,711 | 91,885,094 | 544 |
82947 | Blood glucose (sugar) level | 3,350 | 712,014 | 2,726,003 | 23 |
84450 | Liver enzyme (sgot), level | 1,488 | 711,787 | 3,535,532 | 21 |
J9155 | Injection, degarelix, 1 mg | 128 | 707,305 | 2,305,909 | 10 |
93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | 10,617 | 705,617 | 10,631,710 | 90 |
87801 | Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 598 | 702,275 | 48,225,071 | 155 |
93280 | Programming of dual lead pacemaker system | 7,779 | 700,796 | 31,708,325 | 189 |
J1097 | Phenylephrine 10.16 mg/ml and ketorolac 2.88 mg/ml ophthalmic irrigation solution, 1 ml | 410 | 697,684 | 52,986,234 | 272 |
G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 18,598 | 695,422 | 28,061,775 | 125 |
93295 | Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 4,992 | 695,160 | 17,550,530 | 187 |
J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 35 | 691,908 | 529,750 | 3 |
J2778 | Injection, ranibizumab, 0.1 mg | 753 | 689,609 | 86,529,657 | 601 |
73721 | Mri scan of leg joint without contrast | 9,123 | 684,040 | 65,625,518 | 944 |
88360 | Microscopic genetic analysis of tumor, manual | 5,559 | 682,151 | 32,293,932 | 266 |
86038 | Screening test for autoimmune disorder | 811 | 675,540 | 7,994,770 | 82 |
72110 | X-ray of lower and sacral spine, minimum of 4 views | 13,239 | 667,305 | 16,924,854 | 151 |
77065 | Diagnostic mammography of 1 breast | 8,920 | 665,754 | 30,496,582 | 243 |
A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 651 | 664,794 | 766,664 | 11 |
92020 | Exam of the internal drainage system of eye | 7,492 | 664,399 | 13,454,229 | 70 |
87651 | Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 3,908 | 661,908 | 22,721,206 | 61 |
92507 | Treatment of speech, language, voice, communication, and/or hearing processing disorder | 2,064 | 659,159 | 37,207,968 | 139 |
Q2028 | Injection, sculptra, 0.5 mg | 6 | 652,266 | 420,139 | 4 |
Q4205 | Membrane graft or membrane wrap, per square centimeter | 288 | 652,199 | 676,084,642 | 1,488 |
82962 | Blood glucose (sugar) test performed by hand-held instrument | 6,345 | 649,296 | 2,067,590 | 16 |
20550 | Injection into tendon or ligament | 10,427 | 647,873 | 24,173,500 | 197 |
84155 | Total protein level, blood | 634 | 647,853 | 2,300,363 | 19 |
G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14,958 | 646,399 | 24,471,791 | 105 |
J2795 | Injection, ropivacaine hydrochloride, 1 mg | 215 | 644,374 | 33,518 | 1 |
92202 | Extended exam of the back part of the eye with optic nerve drawing | 2,170 | 642,246 | 7,607,843 | 77 |
G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 9,117 | 640,930 | 15,467,298 | 100 |
77334 | Design and construction of complex radiation treatment device | 4,540 | 639,021 | 38,348,025 | 360 |
76642 | Limited ultrasound scan of 1 breast | 8,780 | 634,205 | 22,942,290 | 217 |
J9041 | Injection, bortezomib, 0.1 mg | 306 | 629,937 | 883,484 | 88 |
87500 | Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique | 926 | 629,864 | 21,633,645 | 63 |
J0640 | Injection, leucovorin calcium, per 50 mg | 818 | 629,119 | 2,199,802 | 26 |
76700 | Complete ultrasound scan of abdomen | 11,417 | 626,785 | 35,730,720 | 288 |
81528 | Gene analysis (colorectal cancer) | 5 | 624,953 | 311,566,053 | 680 |
94726 | Test to determine lung volumes using sensors | 6,789 | 622,345 | 16,222,070 | 116 |
G6002 | Stereoscopic x-ray guidance for localization of target volume for the delivery of radiation therapy | 2,125 | 621,372 | 17,366,115 | 224 |
99443 | Telephone medical discussion with physician, 21-30 minutes | 12,074 | 618,679 | 54,753,774 | 281 |
G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 1,595 | 616,141 | 67,979,748 | 287 |
72170 | X-ray of pelvis, 1-2 views | 15,957 | 612,596 | 5,961,889 | 67 |
62323 | Injection of substance into lower spine canal using imaging guidance | 7,346 | 611,382 | 93,831,219 | 1,345 |
J9190 | Injection, fluorouracil, 500 mg | 1,467 | 600,547 | 1,369,083 | 19 |
99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | 2,946 | 599,999 | 58,385,697 | 203 |
95044 | Test for allergy using skin patch | 373 | 594,737 | 2,351,876 | 18 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.